BioregulatorsResearch profile

Vesugen

Lys-Glu-Asp · KED · Vascular bioregulator

Think of it as a tune-up for your blood vessels.

Vesugen is like a mechanic for your blood vessels, helping them run smoother and potentially last longer. It's a synthetic peptide that's been crafted to communicate directly with the cells lining your blood vessels. The idea is that by getting inside these cells, Vesugen can encourage them to express genes that keep everything in good working order.

Most of the research comes from the Khavinson group, who have looked at how Vesugen might influence aging blood vessels, at least in lab settings and animal studies. They've observed changes that suggest healthier blood vessel function, although it's still early days for understanding how this might apply to humans in the long run.

Who it's for

People interested in maintaining vascular health as they age
Biohackers curious about cutting-edge longevity research
Individuals exploring non-mainstream approaches to wellness

Probably not for you if…

Those looking for FDA-approved treatments
People expecting immediate, well-documented results
Individuals uncomfortable with experimental therapies

Editorial summary for research context · Not medical advice

Mechanism of Action

Vesugen is a synthetic tripeptide (Lys-Glu-Asp) designed as a vascular-tissue bioregulator. Khavinson-group research proposes that short peptides penetrate the cell membrane, enter the nucleus, and modulate tissue-specific gene expression — in this case in vascular endothelial cells and smooth muscle. Preclinical work has focused on endothelial markers and vascular-aging endpoints. Not FDA-approved. Preclinical and limited clinical data from Khavinson group.

Researched Benefits

Vascular endothelial gene modulation

Khavinson-lab studies report modulation of gene expression relevant to endothelial cell markers and vascular homeostasis pathways.

[Khavinson et al. 2013]

Preclinical vascular-aging research

Russian-language studies have examined vascular morphology and endothelial function endpoints in aged rodent models.

[Kuznik et al. 2014]

Endothelial cell-culture activity

In-vitro work on endothelial cell cultures has examined effects on proliferation and aging markers.

Research Protocols

The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.

Intranasal research protocol

Dosage: 100 mcg
Frequency: once daily
Timing: morning
Cycle: 3 weeks

Khavinson-group protocols have typically used 20-30 day cycles, repeated 2x per year.

Reported Side Effects

No significant adverse events reported in published Khavinson-group studies
Transient local irritation with intranasal administration
Long-term human safety data limited

Contraindications

Pregnancy and lactation (no safety data)
Active vascular malignancy (theoretical concern)
Individual hypersensitivity to peptide components

Stacking Partners

Peptides commonly paired with Vesugen in published research and protocol write-ups.

bioregulator

Vendor Pricing

74
LA Peptides
Best $/mg
Size20mg
Total$59.99
/ mg$3.00/mg
In stock
View
66
Purity Peptides
Size20mg
Total$71.99
/ mg$3.60/mg
In stock
View

Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.

Research Papers

Peptide regulation of vascular endothelium: short peptides and gene expression
Khavinson VKh, Linkova NS, et al. · Bulletin of Experimental Biology and Medicine · 2013
Peptidergic regulation of cardiovascular functions in aging
Kuznik BI, et al. · Advances in Gerontology · 2014

Vesugen

Mechanism of Action